Song Hong-Tao, Zhang Qian, Wang Hui-Juan, Guo Xin-Jin, Chen Da-Wei, He Zhong-Gui
Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China.
Pharmazie. 2007 May;62(5):372-7.
In this study the traditional Chinese medicine compound recipe (TCMCR) Shuxiong sustained-release capsules (SXSRC) were prepared by multiparticulate time-controlled explosion technology. First, Shuxiong pellets were prepared with the refined medicinal materials containing in the recipe of Shuxiong tablets. Then, the pellets were coated sequentially with an inner swelling layer containing low-substituted hydroxypropylcellulose as the swelling agent and an outer rupturable layer of ethylcellulose. Finally, SXSRC were developed by encapsulating five kinds of pellets whose respective coating level of outer layer was 0%, 9%, 15%, 18% and 20% at equivalent ratio in hard gelatin capsules. Under the simulated gastrointestinal pH conditions, the in vitro release test of SXSRC was carried out. The value of similarity factor (f2) of hydroxysafflor yellow A and Panax notoginseng saponins, hydroxysafflor yellow A and ferulic acid, Panax notoginseng saponins and ferulic acid was 90.1, 77.3, 87.0, respectively. The release profiles of these three compositions from SXSRC showed a characteristic of obvious sustained-release and no significant difference between them. The results indicated that using multiparticulate time-controlled explosion technology various components in TCMCR with vastly different physicochemical properties could be released synchronously while sustained-releasing. That complies with the organic whole conception of compound compatibility of TCMCR.
本研究采用多颗粒定时爆破技术制备中药复方舒胸缓释胶囊(SXSRC)。首先,用舒胸片处方中的精制药材制备舒胸微丸。然后,依次用含低取代羟丙基纤维素作为溶胀剂的内溶胀层和乙基纤维素外破裂层对微丸进行包衣。最后,将外层包衣水平分别为0%、9%、15%、18%和20%的五种微丸按等比例装入硬明胶胶囊中制成SXSRC。在模拟胃肠道pH条件下,对SXSRC进行体外释放试验。羟基红花黄色素A与三七皂苷、羟基红花黄色素A与阿魏酸、三七皂苷与阿魏酸的相似因子(f2)值分别为90.1、77.3、87.0。这三种成分从SXSRC的释放曲线呈现出明显的缓释特征,且彼此之间无显著差异。结果表明,采用多颗粒定时爆破技术,中药复方中理化性质差异极大的各成分在缓释的同时可同步释放。这符合中药复方配伍的整体观念。